Published in West J Med on February 01, 1995
Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev (2004) 7.51
IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect (2006) 2.39
Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun (1998) 1.44
Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr (2010) 1.19
Severe Mycoplasma disease--rare or underdiagnosed? West J Med (1995) 1.09
A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. Eur J Immunol (2009) 0.96
Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype. BMC Infect Dis (2010) 0.95
Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children. Allergy Asthma Immunol Res (2013) 0.93
Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing. BMC Med Imaging (2009) 0.92
Mycoplasma pneumonia: Clinical features and management. Lung India (2010) 0.92
Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model. J Infect Dis (2011) 0.91
Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am J Physiol Lung Cell Mol Physiol (2008) 0.89
Humoral and cellular immunity in children with Mycoplasma pneumoniae infection: a 1-year prospective study. Clin Diagn Lab Immunol (2005) 0.87
Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia. Front Microbiol (2016) 0.86
Overwhelming postsplenectomy infection due to Mycoplasma pneumoniae in an asplenic cirrhotic patient: case report. BMC Infect Dis (2011) 0.83
Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications. Front Microbiol (2014) 0.83
Fatal outcomes in family transmission of Mycoplasma pneumoniae. Clin Infect Dis (2011) 0.82
Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl. Wien Klin Wochenschr (2007) 0.82
Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model. Results Immunol (2011) 0.77
More on Mycoplasma pneumoniae pneumonia. West J Med (1995) 0.75
The efficacy of glucocorticoid on macrolide resistant Mycoplasma pneumonia in children. Allergy Asthma Immunol Res (2013) 0.75
Acute respiratory distress syndrome related to Mycoplasma pneumoniae infection. Respir Med Case Rep (2016) 0.75
More on Mycoplasma pneumoniae pneumonia. West J Med (1995) 0.75
Unexplained Dyspnea in a Young Adult with Epstein-Barr Virus Infectious Mononucleosis: Pulmonary Involvement or Co-Infection with Mycoplasma pneumoniae Pneumonia? J Clin Med (2017) 0.75
Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc Natl Acad Sci U S A (1962) 14.59
Hospital study of adult community-acquired pneumonia. Lancet (1982) 4.52
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis (1989) 3.92
Mycoplasmas as agents of human disease. N Engl J Med (1981) 3.28
Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis (1979) 3.12
The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med (1975) 3.06
Causes of pneumonia presenting to a district general hospital. Thorax (1981) 2.55
Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med (1972) 2.24
Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis (1973) 2.11
Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis (1983) 1.97
Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med (1993) 1.83
Mycoplasma pneumoniae pneumonia. Chest (1989) 1.67
Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med (1993) 1.58
Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest (1988) 1.55
Mycoplasma pneumoniae as the causative agent for pneumonia in the immunocompromised host. Chest (1991) 1.53
Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature. Am Rev Respir Dis (1980) 1.52
The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am (1978) 1.46
Intravascular coagulation and acute renal failure in a child with mycoplasma infection. Acta Med Scand (1971) 1.44
The clinical spectrum and diagnosis of Mycoplasma pneumoniae infection. Q J Med (1986) 1.41
Central nervous system complications of Mycoplasma pneumoniae infection. Scand J Infect Dis (1969) 1.41
Unusual presentation of Mycoplasma pneumoniae infection. Lancet (1991) 1.41
Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol (1985) 1.39
Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch Pathol Lab Med (1986) 1.37
The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med (1972) 1.35
Severe mycoplasma pneumonia. Thorax (1977) 1.35
Etiologies and characteristic features of pneumonias in a municipal hospital. Am J Med Sci (1973) 1.34
Bacteria, viruses, and mycoplasmas in acute pneumonia in adults. Am Rev Respir Dis (1971) 1.29
Legionnaires' disease. Association with mycoplasma pneumonia and disseminated intravascular coagulation. JAMA (1979) 1.22
Mycoplasma infection in the immunosuppressed leukemic patient. Arch Pathol Lab Med (1980) 1.19
Reduction in the severity of Mycoplasma pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with antithymocyte sera. J Med Microbiol (1974) 1.18
Aetiology of community-acquired pneumonia in hospital treated patients. Scand J Infect Dis (1987) 1.18
Unilateral hyperlucent lung (Swyer-James syndrome) after severe Mycoplasma pneumoniae infection. Am Rev Respir Dis (1978) 1.14
A prospective hospital study of the aetiology of community-acquired pneumonia. Med J Aust (1989) 1.14
Bronchiolitis obliterans due to Mycoplasma pneumoniae. West J Med (1986) 1.13
The occurrence of acute pancreatitis in Mycoplasma pneumoniae infection. Scand J Infect Dis (1974) 1.12
Pulmonary complications following bone marrow transplantation. Clin Chest Med (1990) 1.10
Letter: Mycoplasma pneumoniae septicemia. JAMA (1974) 1.08
Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis. Thorax (1980) 1.07
Mycoplasma pneumonia, Stevens-Johnson syndrome, and chronic obliterative bronchitis. Thorax (1983) 1.07
Effect of Mycoplasma pheumoniae infection on cell-mediated immunity. Infection (1976) 1.04
Adult respiratory distress syndrome caused by Mycoplasma pneumoniae. Chest (1978) 1.03
Second attacks of pneumonia due to Mycoplasma pneumoniae. J Infect Dis (1977) 1.02
Pneumonia caused by Mycoplasma pneumoniae infection. Clin Chest Med (1991) 1.01
Fatal infections associated with Mycoplasma pneumoniae: discussion of three cases with necropsy findings. Mt Sinai J Med (1972) 1.00
Severe disseminated lung disease and bronchiectasis probably due to Mycoplasma pneumoniae. Can Med Assoc J (1977) 0.99
Life-threatening Mycoplasma pneumoniae pneumonia. JAMA (1974) 0.99
Mycoplasmal pneumonia in a patient with rheumatic heart disease. Am J Clin Pathol (1972) 0.97
Immunologic mechanisms suggested in the association of M. pneumoniae infection and extrapulmonary disease: a review. Yale J Biol Med (1984) 0.93
Respiratory failure secondary to Mycoplasma pneumoniae infection. South Med J (1979) 0.91
Two fatal cases of meningoencephalitis associated with Mycoplasma pneumoniae infection. Scand J Infect Dis (1976) 0.90
Mycoplasma pneumoniae pneumonia. Experience at a referral center. West J Med (1984) 0.87
Human mycoplasmal infections: serologic observations. Rev Infect Dis (1985) 0.85
Immunity to mycoplasma infections of the respiratory tract: a review. J R Soc Med (1979) 0.84
Severe Mycoplasma pneumoniae pneumonia. Respiration (1976) 0.84
Severe mycoplasma pneumonia with pleural effusions in a patient with sickle cell-hemoglobin C(SC) disease. Case report and review of the literature. Am J Med (1979) 0.83
Disseminated intravascular coagulation during a fatal Mycoplasma pneumoniae infection. Acta Haematol (1974) 0.82
Lung abscess associated with Mycoplasma pneumoniae infection. Br J Dis Chest (1973) 0.81
Adult respiratory distress syndrome due to Mycoplasma pneumoniae. Chest (1979) 0.81
Lobar pneumonia caused by Mycoplasma pneumoniae. Can Med Assoc J (1981) 0.81
Carbon dioxide retention in Mycoplasma pneumonia. Am Rev Respir Dis (1973) 0.81
Fatal Mycoplasma pneumoniae encephalitis in an adult. Arch Neurol (1980) 0.80
Prevalence of legionellosis among adults: a study of community-acquired pneumonia in France. Infection (1987) 0.80
Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia. Am J Med (1985) 0.80
Progressive heart failure and death associated with Mycoplasma pneumoniae pneumonia. Chest (1982) 0.80
Epidemiologic aspects of M. pneumoniae disease complications: a review. Yale J Biol Med (1984) 0.79
Miliary mycoplasmal pneumonia: a report of six cases. Infection (1976) 0.79
Severe Mycoplasma pneumonia and vesicular eruption in SC hemoglobinopathy. J Pediatr (1978) 0.78
Mycoplasmal pneumonia and adult respiratory distress syndrome: a complication to be recognized. J Natl Med Assoc (1981) 0.78
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 5-1992. A 20-year-old man with diffuse pulmonary infiltrates and disseminated intravascular coagulation. N Engl J Med (1992) 0.78
Successful weaning from controlled ventilation despite high deadspace-to-tidal volume ratio. Anesthesiology (1973) 0.77
Virus and Mycoplasma respiratory infections. Adv Cardiopulm Dis (1969) 0.77
Circulating immune complexes in patients with mycoplasmal pneumonia. Am Rev Respir Dis (1984) 0.77
Acute respiratory failure due to atypical pneumonia. Case report. Mo Med (1983) 0.76
Severe Mycoplasma pneumoniae infection in otherwise healthy siblings. J Pediatr (1979) 0.76
Clinical validity of helical CT being interpreted as negative for pulmonary embolism: implications for patient treatment. AJR Am J Roentgenol (1999) 1.85
Pulmonary embolism: diagnosis with spiral CT and ventilation-perfusion scanning--correlation with pulmonary angiographic results or clinical outcome. Radiology (1998) 1.66
Geriatric respiratory medicine. Chest (1998) 1.65
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group. J Infect Dis (1996) 1.21
Long-term functional outcome after intensive care. J Am Geriatr Soc (1999) 0.93
Endotoxin increases pulmonary vascular protein permeability in the dog. J Appl Physiol (1985) (1986) 0.88
Antiarrhythmic agents diminish thiourea-induced pulmonary vascular protein leak in rats. J Appl Physiol (1985) (1987) 0.83
Cigarette smoking and health. Am Rev Respir Dis (1985) 0.82
Risk factors for upper gastrointestinal bleeding in intensive care unit patients: role of helicobacter pylori. Federal Hyperimmune Immunoglobulin Therapy Study Group. Crit Care Med (1996) 0.80
Pentoxifylline lessens the endotoxin-induced increase in albumin clearance across pulmonary artery endothelial monolayers with and without neutrophils. Am J Respir Cell Mol Biol (1991) 0.78
Peripheral bypass-induced pulmonary and coronary vascular injury. Association with increased levels of tumor necrosis factor. Circulation (1993) 0.76
The heart and lungs at extreme altitude. Thorax (1994) 0.75
A 48-year-old smoker with cough and weight loss. Chest (2000) 0.75
Relief of right ventricular angina and increased exercise capacity with long-term oxygen therapy. Chest (1991) 0.75